| 000 | 01677 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517030242.0 | ||
| 264 | 0 | _c20160324 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1365-2222 | ||
| 024 | 7 |
_a10.1111/cea.12558 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKlemans, R J B | |
| 245 | 0 | 0 |
_aObjective eliciting doses of peanut-allergic adults and children can be combined for risk assessment purposes. _h[electronic resource] |
| 260 |
_bClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _cJul 2015 |
||
| 300 |
_a1237-44 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAllergens _xadministration & dosage |
| 650 | 0 | 4 |
_aAntigens, Plant _xadministration & dosage |
| 650 | 0 | 4 |
_aArachis _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeanut Hypersensitivity _xdiagnosis |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBlom, W M | |
| 700 | 1 | _avan Erp, F C | |
| 700 | 1 | _aMasthoff, L J N | |
| 700 | 1 | _aRubingh, C M | |
| 700 | 1 | _avan der Ent, C K | |
| 700 | 1 | _aBruijnzeel-Koomen, C A F M | |
| 700 | 1 | _aHouben, G F | |
| 700 | 1 | _aPasmans, S G M A | |
| 700 | 1 | _aMeijer, Y | |
| 700 | 1 | _aKnulst, A C | |
| 773 | 0 |
_tClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _gvol. 45 _gno. 7 _gp. 1237-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cea.12558 _zAvailable from publisher's website |
| 999 |
_c24830676 _d24830676 |
||